ClinicalTrials.gov record
Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis
COMPLETED · NCT02663895
Trial record
NCT IDNCT02663895
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
PHASE2
Enrollment
12
Conditions
Systemic Sclerosis, Calcinosis
Interventions
Oral treprostinil
Locations
Stanford University School of Medicine, Palo Alto, California, United States
Indexed topics
Last update
2021-06-08